跳至主要内容
临床试验/NCT01545414
NCT01545414已完成3 期

Internet-based CBT for Depression and Anxiety in Parkinson's Disease: a Pilot Study and Randomized Controlled Trial

Karolinska Institutet1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2012年2月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
150
试验地点
1
主要终点
Change (from baseline) in HADS

研究概览

简要总结

The purpose of this project is to develop and evaluate Internet-based Cognitive Behavioral Therapy (ICBT) for Parkinson's Disease (PD) patients with concurrent depression or anxiety symptoms. All treatment in this project is given as an adjunct to Standard Medical Treatment (SMT). ICBT will be compared to an Internet-based active control treatment (ICONTROL) and to SMT alone. It is hypothesized that both active treatments will be superior to SMT, and that ICBT will be superior to ICONTROL, in reducing symptoms of depression and anxiety.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of Parkinson's Disease
  • At least mild to moderate depression or anxiety defined as HADS-A or HADS-D > 7

排除标准

  • Has a high alcohol or drug use assessed by the AUDIT / DUDIT and assessment interview
  • Somatic or psychiatric problems that are directly contraindicated or seriously hamper the implementation of the treatment (eg, psychotic disorders or bipolar disorder)
  • Difficulties that hamper the use of a computer
  • The patient states difficulties in finding enough time for treatment
  • Too low cognitive functioning defined as MoCA < 24
  • Too severe depression, defined as MADRS-S over 30
  • Too high suicidal risk defined as more than 4 points on the MADRS-S question 9 or according to the structured assessment interview

结局指标

主要结局

Change (from baseline) in HADS

时间窗: 12 weeks (Post), 3 and 6 months (FU)

Hospital Anxiety and Depression Scale - self rating, to measure anxiety and depression

次要结局

  • Change (from baseline) in MADRS-S(12 weeks (Post), 3 and 6 months (FU))
  • Change (from baseline) in ISI(12 weeks (Post), 3 and 6 months (FU))
  • Change (from baseline) in PDQ-8(12 weeks (Post), 3 and 6 months (FU))
  • Change (from baseline) in NMSQuest(12 weeks (Post), 3 and 6 months (FU))
  • Change (from baseline) in EQ-5D(12 weeks (Post), 3 and 6 months (FU))
  • Change (from baseline) in SDS(12 weeks (Post), 3 and 6 months (FU))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Viktor Kaldo

Principal Investigator

Karolinska Institutet

研究点 (1)

Loading locations...

相似试验